MRAP

MRAP (melanocortin-2 receptor accessory protein) is a single-transmembrane accessory protein that forms antiparallel homodimers and serves as an essential trafficking and signaling cofactor for melanocortin receptors, with broader modulatory roles across metabolic GPCRs. MRAP facilitates MC2R export from the endoplasmic reticulum to the plasma membrane and enables ACTH binding and Gs-coupled cAMP signaling through two separable functions—a trafficking function dependent on the transmembrane-proximal region and a signaling function mediated by an extracellular 'seat-belt' that wraps around ACTH to stabilize receptor activation, as revealed by cryo-EM (PMID:36588120, PMID:19028547). While MRAP promotes MC2R surface expression and homodimerization, it suppresses signaling of MC1R, MC3R, MC4R, and MC5R, and can trap MC5R intracellularly by disrupting its dimerization, establishing MRAP as a bidirectional regulator of the melanocortin receptor family (PMID:19329486, PMID:19535343). Loss-of-function mutations in MRAP cause familial glucocorticoid deficiency type 2, and Mrap-null mice exhibit neonatal lethality, isolated glucocorticoid deficiency, and impaired adrenal progenitor differentiation with dysregulation of WNT4/β-catenin and sonic hedgehog pathways (PMID:15654338, PMID:29879378).

1. 2005 High

   The gene underlying familial glucocorticoid deficiency type 2 was unknown; identification of MRAP mutations in FGD2 patients and demonstration that MRAP interacts with MC2R and promotes its ER-to-surface trafficking established MRAP as a disease-causing accessory protein for the ACTH receptor.

   Evidence SNP array mapping in FGD2 families, MRAP mutation identification, MC2R interaction and trafficking assays

   PMID:15654338

   Open questions at the time

   • Mechanism by which MRAP promotes MC2R trafficking not determined
   • Membrane topology of MRAP unknown
   • Whether MRAP acts on other MCRs untested
2. 2007 High

   How MRAP is organized in the membrane was unclear; demonstration that MRAP forms antiparallel homodimers with dual topology—the first such arrangement in a eukaryotic protein—explained how a single-pass transmembrane protein can present functional domains on both sides of the membrane and form a stable complex with MC2R required for glycosylation, surface delivery, and ACTH signaling.

   Evidence Epitope-tagged topology mapping, glycosylation mutagenesis, co-IP of differentially tagged MRAPs, surface ELISA and cAMP assays in CHO and adrenal cells

   PMID:18077336

   Open questions at the time

   • Atomic structure of the antiparallel dimer not resolved
   • Whether antiparallel arrangement is required for MC2R activation unknown
3. 2008 High

   Whether MRAP's trafficking and signaling functions are mechanistically identical was unresolved; mutagenesis showed that a transmembrane-proximal N-terminal sequence governs dual topology, while distinct N-terminal regions are separately required for MC2R surface delivery versus ACTH binding and cAMP generation, establishing two separable MRAP functions.

   Evidence Deletion and alanine-substitution mutagenesis with surface expression, ACTH binding, and cAMP readouts

   PMID:19028547

   Open questions at the time

   • Precise residues contacting MC2R versus ACTH not identified
   • Whether both MRAP orientations contribute equally to each function unknown
4. 2009 High

   MRAP's specificity for MC2R was assumed; discovery that MRAP and MRAP2 interact with all five melanocortin receptors (MC1R–MC5R) and exert opposing effects—promoting MC2R signaling while suppressing MC1R/MC3R/MC4R/MC5R responsiveness—reframed MRAP as a bidirectional regulator of the entire MCR family, with receptor-specific mechanisms including differential effects on receptor dimerization and intracellular retention.

   Evidence Co-IP across all five MCRs, surface ELISA, cAMP dose-response, BiFC dimerization assays, confocal microscopy

   PMID:19329486 PMID:19535343

   Open questions at the time

   • Structural basis for receptor-selective effects of MRAP unknown
   • In vivo relevance of MRAP suppression of non-MC2R receptors not tested
5. 2018 High

   The in vivo consequences of MRAP loss beyond glucocorticoid deficiency were unexplored; Mrap-null mice revealed that MRAP is required for adrenal progenitor differentiation and cortex zonation through WNT4/β-catenin and sonic hedgehog pathways, and an elephant shark ortholog study showed MRAP can enhance MCR signaling sensitivity without affecting trafficking, demonstrating an evolutionarily conserved signaling-specific function.

   Evidence Mrap-knockout mouse with histology, corticosterone rescue, WNT4/SHH pathway analysis; elephant shark MRAP1 co-expression in CHO cells with surface ELISA and cAMP assays

   PMID:29879378 PMID:30468718

   Open questions at the time

   • Whether MRAP directly signals to WNT4/SHH or acts indirectly through MC2R is unresolved
   • Whether the signaling-only mode of shark MRAP applies in mammalian tissues unknown
6. 2022 Medium

   Whether MRAP acts beyond the melanocortin receptor family was unknown; a broad interaction screen identified MRAP1 interactions with 36 metabolic-related GPCRs and showed MRAP1/2 modulate their surface translocation and signaling, substantially expanding the functional scope of MRAPs.

   Evidence Single-cell transcriptomics, co-expression network analysis, protein-protein interaction and cAMP assays across 36 GPCRs, in vivo AAV-shRNA knockdown of MRAP2 in mouse hypothalamus

   PMID:36314066

   Open questions at the time

   • Mechanistic depth for most non-MCR GPCR interactions is limited
   • Whether MRAP1 versus MRAP2 have distinct GPCR specificities in vivo is unclear
   • Physiological significance of many identified interactions not validated
7. 2023 High

   The atomic mechanism by which MRAP enables ACTH recognition was unknown; a cryo-EM structure of the ACTH–MC2R–Gs–MRAP1 complex revealed that MRAP1 adopts a sharp extracellular kink and wraps around ACTH in a 'seat-belt' configuration, directly stabilizing ligand binding and receptor activation, with key contacts validated by mutagenesis.

   Evidence Cryo-EM structure determination of the ternary complex, mutagenesis of interface residues

   PMID:36588120

   Open questions at the time

   • Structure of the MRAP antiparallel dimer without ligand/receptor not determined
   • How MRAP suppresses non-MC2R receptor signaling at the structural level remains unknown

• Key unresolved questions include the structural basis by which MRAP suppresses MC1R/MC3R/MC4R/MC5R signaling, whether MRAP's broader GPCR interactions are physiologically relevant beyond the melanocortin system, and how MRAP loss drives WNT4/β-catenin and SHH pathway dysregulation in adrenal progenitors.
• No structure of MRAP with a non-MC2R melanocortin receptor
• Mechanism linking MRAP to WNT4/SHH signaling not established
• In vivo tissue-specific MRAP1 versus MRAP2 functional partitioning not defined